21:29 EDT Correct: Theriva Biologics prices $2.5M public offering at $1.75 per share
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TOVX:
- Theriva Biologics Advances VCN-01 in VIRAGE Phase 2b Trial
- Theriva Biologics achieves target patient enrollment in VIRAGE Phase 2b trial
- Theriva Biologics Secures Funding for Viral Therapy Innovation
- Theriva Biologics awarded manufacturing funding from Spanish government
- Theriva Biologics files to sell 2.17M shares of common stock, warrants